# EDGAR Filing Document

**Accession Number:** 0001421642
**File Stem:** 0001104659-26-010969
**Filing Date:** 2026-2
**Character Count:** 4616
**Document Hash:** e15d849ffaa828b3d88c4467b98ac1b9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-010969.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001104659-26-010969

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Satellos Bioscience Inc.
- **CENTRAL INDEX KEY:** 0001421642

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43107
- **FILM NUMBER:** 26603578

**BUSINESS ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1
- **BUSINESS PHONE:** 416-708-0522

**MAIL ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ICO THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20071218

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-A**

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES**

**PURSUANT TO SECTION 12(b) OR 12(g) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**SATELLOS BIOSCIENCE INC.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp;**Not applicable** |
| &nbsp;&nbsp;(State of incorporation or organization) | &nbsp;&nbsp;(IRS Employer Identification No.) |
| &nbsp;&nbsp;**200 Bay Street, Suite 2800, Toronto, ON M5J 2J1,<br> Canada** | &nbsp;&nbsp;**M5J 2J1** |
| &nbsp;&nbsp;(Address of principal executive offices) | &nbsp;&nbsp;(Zip Code) |

---

**Securities to be registered pursuant to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| &nbsp;&nbsp;Title of each class | &nbsp;&nbsp;Name of each exchange on which |
| &nbsp;&nbsp;to be so registered | &nbsp;&nbsp;each class is to be registered |
| &nbsp;&nbsp;**Common Shares** | &nbsp;&nbsp;**The Nasdaq Stock Market LLC** |

---

If this Form 8-A relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is to become effective pursuant to General Instruction A.(c), please check the following box. ⌧

If this Form 8-A relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is to become effective pursuant to General Instruction A.(d), please check the following box. ◻

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box ◻

**Securities Act registration statement file number to which this form relates: 333-293229**

**Securities to be registered pursuant to Section 12(g) of the Act: None**

**INFORMATION REQUIRED IN REGISTRATION STATEMENT**

**Item 1.** **Description of Registrant's Securities to be Registered.**

The securities to be registered are the common shares in the capital ("**Common Shares**") of Satellos Bioscience Inc. (the "**Registrant**"). The description of the Registrant's Common Shares under the section captioned "Description of Common Shares" in the short form base shelf prospectus and under the sections captioned, "Certain Canadian Federal Income Tax Considerations", and "Material United States Federal Income Tax Considerations" in the prospectus supplement to the short form base shelf prospectus, each included in the Registrant's registration statement on Form F-10 (File No. 333-293229) (the "**Registration Statement**"), initially filed with the Securities and Exchange Commission on February 5, 2026, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by reference.

**Item 2.** **Exhibits.**

Under the "Instructions as to Exhibits" section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

**SIGNATURE**

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| Dated: February 5, 2026 | Dated: February 5, 2026 |
| **SATELLOS BIOSCIENCE INC.** | **SATELLOS BIOSCIENCE INC.** |
| By: | /s/ Elizabeth Williams, CPA, CA |
|  | Elizabeth Williams, CPA, CA |
|  | Chief Financial Officer |

---